Publications

Researchers affiliated with the Centre for Drug Safety Science have published more than 700 peer-reviewed journal articles that have made significant contribution to the relevant academic disciplines. Below, we highlight some of the landmark published research.

Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients

  • Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, Farrar K, Park BK, Breckenridge AM. Adverse drug reactions as cause of admission to hopsital: prospective analysis of 18,820 patients. BMJ 2004; 329:15
  • Read the publication

Adverse Drug Reactions in Hospital In-Patients: A Prospective Analysis of 3695 Patient-Episodes

  • Davies EC, Green CF, Taylor S, Williamson PR, Mottram DR, Pirmohamed M. Adverse Drug Reactions in Hospital In-Patients: A Prospective Analysis of 3695 Patient-Episodes. PLOS ONE 4(2): e4439, 2009
  • Read the publication

Drug repurposing: progress, challenges and recommendations

  • Pushpakom S, Iorio F, Eyers PA, Escott J, Hopper S, Wells A, Doig A, Guilliams T, latimer J, McNamee C, Norris A, Sanseau P, Cavalla D, Pirmohamed M. Drug repurposing: progress, challenges and recommendations. Nature Reviews Drug Discovery volume 18, pages 41–58 (2019).

Susceptibility to corticosteroid-induced adrenal suppression: a genome-wide association study

  • Hawcutt D, Francis B, Carr DF, Jorgensen AL, Yin P, Wallin N, O'Hara N, Zhang EJ, Bloch KM, Ganguli A et al. Susceptibility to corticosteroid-induced adrenal suppression: a genome-wide association study. Lancet Respiratory Medicine, 6 (6). 442 - 450 (2018).
  • Read the publication

Back to: Centre for Drug Safety Science